Researchers have found in a new study that common salt may serve as a safe and effective non-pharmacological home treatment ...

Enrollment remains on track in Phase 2 pivotal portion of PYNNACLE trial evaluating rezatapopt as monotherapy in platinum-resistant/refractory ovarian cancer patients with a TP53 Y220C ...

DaVita Inc. DVA has been gaining from its business model. The optimism, led by a solid fourth-quarter 2025 performance and ...

The dialysis market is expected to expand at a compound annual growth rate (CAGR) of around 8% over the forecast period. This ...

The Phase 1 SPARC trial evaluates safety, tolerability, and pharmacokinetics across multiple OPT101 concentrations during ...

Stage 1 mesothelioma is localized. The cancer is confined to one side of the chest lining or one area of the abdomen and has not spread to lymph nodes or distant organs. At this stage, treatment may ...

The FDA has granted breakthrough device designation for an implantable insulin pump designed for people with type 1 diabetes, according to an industry press release. The implantable device (Portal ...

After spending decades helping others, Troy "T-bone" Wilson is asking for support as the long time Victoria mentor, volunteer ...

The current kidney care model—focused on late-stage disease and in-center hemodialysis—is unsustainable, because of costs, environmental burden, poor outcomes, and reduced quality of life.

Researchers at Nagoya University have reported that ovarian cancer cells form hybrid clusters with mesothelial cells in abdominal fluid, a process that appears to accelerate tissue invasion and ...

Enrollment remains on track in Phase 2 pivotal portion of PYNNACLE trial evaluating rezatapopt as monotherapy in platinum-resistant/refractory ovarian cancer patients with a TP53 Y220C mutationRezatap ...

"The prognosis was so poor that the hospital called in grief counselors to speak with my family and help prepare them." View ...